Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients with Type 2 Diabetes: A Randomized Trial

Những quyển sách tương tự

• Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study
  Bằng: Stack, Austin G, et al.
  Được phát hành: (2020)
• A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases
  Bằng: Leander, Jacob, et al.
  Được phát hành: (2021)
• The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
  Bằng: Becker, Michael A, et al.
  Được phát hành: (2010)
• The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
  Bằng: Jackson, Robert L, et al.
  Được phát hành: (2012)
• Trends in Utilization of Urate-Lowering Therapies Following the FDA’s Boxed Warning to Febuxostat in the U.S.
  Bằng: Kim, Seoyoung C, et al.
  Được phát hành: (2021)